Femoral osteolysis following total hip replacement

Postgraduate Medical Journal

Volumn 83, Issue 979, 2007, Pages 312-316

  Dattani, R ^a  

^a ST HELIER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; CALCIUM PHOSPHATE; COLLAGEN; CYTOKINE; HYDROXYAPATITE; TITANIUM;

AGING; BONE DEVELOPMENT; BONE GRAFT; BONE RADIOGRAPHY; BONE REMODELING; CERAMICS; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; FEMUR; FEMUR HEAD; GENE THERAPY; HEALTH CARE COST; HIP ARTHROPLASTY; HIP DISLOCATION; HUMAN; ILIAC CREST; MESENCHYMAL STEM CELL; OSTEOBLAST; OSTEOLYSIS; PHAGOCYTOSIS; POSTOPERATIVE COMPLICATION; PROSTHESIS FAILURE; QUALITY OF LIFE; REVIEW; TOTAL HIP PROSTHESIS;

ARTHROPLASTY, REPLACEMENT, HIP; FEMUR; HUMANS; OSTEOLYSIS; REOPERATION;

EID: 34249092006     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.2006.053215     Document Type: Review

References (64)

1. Clohisy JC, Calvert G, Tull F, et al. Reasons for revision hip surgery. A retrospective review. Clin Orthop 2004;429:188-92.
2. Harris WH. Wear and periprosthetic osteolysis: the problem. Clin Orthop 2001;393:66-70.
3. NIH Consensus Development Panel on Total Hip Replacement. NIH consensus conference: total hip replacement. JAMA 1995;273:1950-6.
4. Malchau H, Herberts P, Eisler T, et al. The Swedish Total Hip Replacement Register. J Bone Joint Surg Am 2002;84-A(Suppl 2):2-20.
5. Zicat B, Engh CA, Gokcen E. Patterns of osteolysis around total hip components inserted with and without cement. J Bone Joint Surg Am 1995;77:432-9.
6. Clohisy JC, Harris WH. The Harris-Galante uncemented femoral component in primary total hip replacement at 10 years. J Arthroplasty 1999;14:915-17.
7. Hellman EJ, Capello WN, Feinberg JR. Omnifit cementless total hip arthroplasty. A 10-year average followup. Clin Orthop 1999;364:164-74.
8. Dorr LD, Lewonowski K, Lucero M, et al. Failure mechanisms of anatomic porous replacement I cementless total hip replacement. Clin Orthop 1997;334:157-67.
9. Goldring SR, Schiller AL, Roelke M, et al. The synovial-like membrane at the bone-cement interface in loose total hip replacements and its proposed role in bone lysis. J Bone Joint Surg Am 1983;65:575-84.
10. Rubash HE, Sinha RK, Shanbhag AS, et al. Pathogenesis of bone loss after total hip arthroplasty. Orthop Clin North Am 1998;29:173-86.
11. Jasty M, Moloney WJ, Bragdon CR, et al. Histomorphological studies of the long-term skeletal responses to well fixed cemented femoral components. J Bone Joint Surg Am 1990;72:1220-9.
12. Huiskes, Boeklagen R. Mathematical shape optimization of hip prosthesis design. J Biomech 1989;22:793-804.
13. Weinans, Huiskes R, Grootenboer HJ. Effects of fit and bonding characteristics of femoral stems on adaptive bone remodeling. J Biomech Eng 1994;116:393-400.
14. Harris WH, McCarthy JC Jr, O'Neill DA. Femoral component loosening using contemporary techniques of femoral cement fixation. J Bone Joint Surg Am 1982;64:1063-7.
15. Taylor M, Tanner KE. Fatigue failure of cancellous bone: a possible cause of implant migration and loosening. J Bone Joint Surg Br 1997;79:181-2.
16. SchuLte KR, Callaghan JJ, Kelley SS, et al. The outcome of Charnley total hip arthroplasty with cement after a minimum twenty-year follow-up. J Bone Joint Surg Am 1993;75:961-75.
17. Aspenberg P, Van d V. Fluid pressure may cause periprosthetic osteolysis. Particles are not the only thing. Acta Orthop Scand 1998;69:1-4.
18. Aspenberg P, Van d, V. Migration, particles, and fluid pressure. A discussion of causes of prosthetic loosening. Clin Orthop 1998;352:75-80.
19. Campbell P, Ma S, Yeom B, et al. Isolation of predominantly submicron-sized UHMWPE wear particles from periprosthetic tissues. J Biomed Mater Res 1995;29(1):127-131.
20. Maloney WJ, Smith RL, Schmalzried TP, et al. Isolation and characterization of wear particles generated in patients who have had failure of a hip arthroplasty without cement. J Bone Joint Surg Am 1995;77:1301-10.
21. Margevicius KJ, Bauer TW, McMahon JT, et al. Isolation and characterization of debris in membranes around total joint prostheses. J Bone Joint Surg Am 1994;76:1664-75.
22. Jacobs JJ, Roebuck KA, Archibeck M, et al. Osteolysis: basic science. Clin Orthop 2001;393:71-7.
23. Schmalzried TP, Jasty M, Harris WH. Periprosthetic bone loss in total hip arthroplasty. Polyethylene wear debris and the concept of the effective joint space. J Bone Joint Surg Am 1992;74:849-63.
24. Anthony PP, Gie GA, Howie CR, et al. Localised endosteal bone lysis in relation to the femoral components of cemented total hip arthroplasties. J Bone Joint Surg Br 1990;72:971-9.
25. Zicat B, Engh CA, Gokcen E. Patterns of osteolysis around total hip components inserted with and without cement. J Bone Joint Surg Am 1995;77:432-9.
26. Dumbleton JH, Manley MT, Edidin AA. A literature review of the association between wear rate and osteolysis in total hip arthroplasty. J Arthroplasty 2002;17:649-61.
27. National Institute for Clinical Excellence. The effectiveness and cost effectiveness of different prostheses for primary total hip replacement. London: NICE, 2000.
28. National Audit Office. Hip replacements: an update- report by the comptroller and auditor general; HC 956 Session 2002- 2003.
29. Pellicci PM, Wilson PD Jr, Sledge CB, et al. Long-term results of revision total hip replacement. A follow-up report. J Bone Joint Surg Am 1985;67:513-16.
30. Amstutz HC, Ma SM, Jinnah RH, et al. Revision of aseptic loose total hip arthroplasties. Clin Orthop 1982;170:21-33.
31. Salvati EA, Bullough P, Wilson PD Jr. Intrapelvic protrusion of the acetabular component following total hip replacement. Clin Orthop 1975;111:212-27.
32. Stauffer RN. Ten-year follow-up study of total hip replacement. J Bone Joint Surg Am 1982;64:983-90.
33. Behairy Y, Jasty M. Bone grafts and bone substitutes in hip and knee surgery. Orthop Clin North Am 1999;30:661-71.
34. Garbuz DS, Masri BA, Czitrom AA. Biology of allografting. Orthop Clin North Am 1998;29:199-204.
35. Vaccaro AR. The role of the osteoconductive scaffold in synthetic bone graft. Orthopedics 2002;25(5 Suppl):s571-8.
36. Berry DJ, Muller ME. Revision arthroplasty using an anti-protrusio cage for massive acetabular bone deficiency. J Bone Joint Surg Br 1992;74:711-15.
37. Padgett DE, Kull L, Rosenberg A, et al. Revision of the acetabular component without cement after total hip arthroplasty. Three to six-year follow-up. J Bone Joint Surg Am 1993;75:663-73.
38. Hozack WJ, Bicalho PS, Eng K. Treatment of femoral osteolysis with cementless total hip revision. J Arthroplasty 1996;11:668-72.
39. Sommerville SM, Johnson N, Bryce SL, et al. Contamination of banked femoru head allograft: incidence, bacteriology and donor follow up. Aust N Z J Surg 2000;70:480-4.
40. Tomford WW. Transmission of disease through transplantation of musculoskeletal allografts. J Bone Joint Surg Am 1995;77:1742-54.
41. Betz RR. Limitations of autograft and allograft: new synthetic solutions. Orthopedics 2002;25(5 Suppl):s561-70.
42. Boyce T, Edwards J, Scarborough N. Allograft bone. The influence of processing on safety and performance. Orthop Clin North Am 1999;30:571-81.
43. Gross AE, McKee NH, Pritzker KP, et al. Reconstruction of skeletal deficits at the knee. A comprehensive osteochondral transplant program. Clin Orthop 1983;174:96-106.
44. Bos GD, Goldberg VM, Zika JM, et al. Immune responses of rats to frozen bone allografts. J Bone Joint Surg Am 1983;65:239- 46.
45. Galea G, Kopman D, Graham BJ. Supply and demand of bone allograft for revision hip surgery in Scotland. J Bone Joint Surg Br 1998;80:595-9.
46. Bucholz RW, Carlton A, Holmes RE. Hydroxyapatite and tricalcium phosphate bone graft substitutes. Orthop Clin North Am 1987;18:323-34.
47. Delloye C, Cnockaert N, Cornu O. Bone substitutes in 2003: an overview. Acta Orthop Belg 2003;69:1-8.
48. Toms AD, Barker RL, Jones RS, et al. Impaction bone-grafting in revision joint surgery. J Bone Joint Surg Am 2004;86:2050-60.
49. Dorr LD, Wan Z. Ten years of experience with porous acetabular components for revision surgery. Clin Orthop Relat Res 1995;319:191-200.
50. Barrack RL, Sawhney J, Hsu J, et al. Cost analysis of revision total hip arthroplasty: a 5-year follow-up study. Clin Orthop Relat Res 1999,369:175-8.
51. Crowe JF, Sculco TP, Kahn B. Revision total hip arthroplasty: hospital cost and reimbursement analysis. Clin Orthop Relat Res 2003;413:175-82.
52. Millett PJ, Allen MJ, Bostrom MP. Effects of alendronate on particle-induced osteolysis in a rat model. J Bone Joint Surg Am 2002;84:236-49.
53. Shanbhag AS, Hasselman CT, Rubash HE. The John Charnley Award. Inhibition of wear debris mediated osteolysis in a canine total hip arthroplasty model. Clin Orthop Relat Res 1997;344:33-43.
54. Dennis JE, Haynesworth SE, Young RG, et al. Osteogenesis in marrow-derived mesenchymal cell porous ceramic composites transplanted subcutaneously: effect of fibronectin and laminin on cell retention and rate of osteogenic expression. Cell Transplant 1992;1:23-32.
55. Haynesworth SE, Goshima J, Goldberg VM, et al. Characterization of cells with osteogenic potential from human marrow. Bone 1992;13:81-8.
56. Jaiswal N, Haynesworth SE, Caplan AI, et al. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 1997;64:295-312.
57. Bruder SP, Jaiswal N, Haynesworth SE. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 1997;64:278-94.
58. Kadiyala S, Young RG, Thiede MA, et al. Culture expanded canine mesenchymal stem cells possess osteochondrogenic potential in vivo and in vitro. Cell Transplant 1997;6:125-34.
59. Bruder SP, Kraus KH, Goldberg VM, et al. The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects. J Bone Joint Surg Am 1998;80:985-96.
60. Friedlaender GE, Perry CR, Cole JD, et al. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am, 2001;83-A(Suppl 1, (Pt 2)):S151-8.
61. Sandhu HS, Grewal HS, Parvataneni H. Bone grafting for spinal fusion. Orthop Clin North Am 1999;30:685-98.
62. Boden SD, Titus L, Hair G, et al. Lumbar spine fusion by local gene therapy with a cDNA encoding a novel osteoinductive protein (LMP-1). Spine 1998;23:2486-92.
63. Hawley RG, Lieu FH, Fong AZ, et al. Versatile retroviral vectors for potential use in gene therapy. Gene Therapy 1994;1:136-8.
64. Wooley PH, Schwarz EM. Aseptic Loosening. Gene Therapy 2004;11:402-7.